Mapping the Evolution of Solid Organ Xenotransplantation Research:A Systematic Review

Ivana Juric1,2, Marc Raynaud1, Lea Skoric3

  • 1INSERM, PARCC, Paris Institute for Transplantation and Organ Regeneration, Université de Paris Cité, Paris, France.

Xenotransplantation
|June 24, 2025
PubMed
Abstract

Insights

This study analyzes xenotransplantation publications, revealing two research peaks driven by gene editing and early pig-to-human transplants. It highlights the need for more original research and broader engagement in general medical journals.

Area of Science:

  • Medical research
  • Transplantation science
  • Biomedical engineering

Background:

  • Xenotransplantation offers a potential solution to the critical organ shortage, leading to a surge in scientific publications.
  • Despite numerous studies, a comprehensive analysis of the research dynamics and publication trends in xenotransplantation is lacking.

Purpose of the Study:

  • To systematically assess the publication activity and research trends in the field of xenotransplantation.
  • To identify key areas, publication patterns, and geographical distribution of xenotransplantation research.

Main Methods:

  • A systematic literature search was conducted up to November 22, 2024, including solid organ and islet xenotransplantation studies.
  • Data extracted included publication details, journals, organ types, donor species, and thematic focus.

Main Results:

  • Out of 2944 publications, 706 met the inclusion criteria, with original articles and reviews forming the majority.
  • Publication activity showed peaks in the 1990s (gene editing) and early 2020s (first pig-to-human transplant).
  • The USA led publications, with heart, kidney, and islets being the most studied, focusing on rejection, immune mechanisms, and gene editing.

Conclusions:

  • This systematic assessment reveals growing global interest and evolving research focus in xenotransplantation.
  • A low proportion of original data publications indicates a need for increased primary research.
  • Limited representation in general medical journals suggests a need to broaden audience engagement as clinical trials advance.